Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis

Journal of the American Society of Nephrology

Volumn 7, Issue 1, 1996, Pages 23-32

  Hogan, Susan L ^a   Nachman, Patrick H ^a   Wilkman, Alice S ^a   Jennette, J Charles ^a   Falk, Ronald J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Patient survival; Prospective cohort; Renal survival; Vasculitis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; MARKER; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGE; AGED; ARTICLE; GLOMERULONEPHRITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; RACE; SURVIVAL; VASCULITIS;

EID: 0030052126     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Falk RJ: ANCA-associated renal disease. Nephrology Forum. Kidney Int 1990;38:998-1010.
2. Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic crescentic glomerulonephritis. N Engl J Med 1988;318:1651-1657.
3. Falk RJ, Hogan S, Carey TS, Jennette JC, The Glomerular Disease Collaborative Network: Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. Ann Intern Med 1990;113:656-663.
4. Nolle B, Specks U, Ludemann J, Rohrbach MS, DeRemee RA, Gross WL: Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med 1989;111:28-40.
5. Cohen-Tervaert JW, Goldschmeding R, Elema JD, et al.: Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 1990;37:799-806.
6. Keller F, Oehlenberg B, Kunzendorf U, Schwartz A, Offermann G: Long-term treatment and prognosis of rapidly progressive glomerulonephritis. Clin Nephrol 1989;13:190-197.
7. Gans ROB, Kuizinga MC, Goldschmeding R, et al: Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantibodies. Nephron 1993;64:182-188.
8. Fuiano G, Cameron JS, Raftery M, Hartley BH, Williams DG, Ogg CS: Improved prognosis of renal microscopic polyarteritis in recent years. Nephrol Dial Transplant 1988;3:383-391.
9. Guillevin BL, Le Thi Huong Du, Godeau P, Jais P, Wechsler B: Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss Angiitis: A study in 165 patients. Br J Rheumatol 1988;27:258-264.
10. Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM: Microscopic polyarteritis: Presentation, pathology and prognosis. Q J Med 1985;56:467-483.
11. Andrassy K, Kuster S, Waldherr R, Ritz E: Rapidly progressive glomerulonephritis: Analysis of prevalence and clinical course. Nephron 1991;59:206-212.
12. Briedigkeit L, Kettritz R, Gobel U, Natusch RL: Prognostic factors in Wegener's granulomatosis. Postgrad Med J 1993;69:856-861.
13. Fauci AS, Haynes BF, Katz P: The spectrum of vasculitis: Clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978;89:660-676.
14. Hoffman GS, Kerr GS, Leavitt RY, et al.: Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 1992;116:488-498.
15. Pusey CD, Lockwood CM. Plasma exchange in immunosuppressive drugs in the management of severe glomerulonephritis. In: Tindall RSH, Ed. Therapeutic Apheresis and Plasma Perfusion. New York: AR Liss; 1982:91-104.
16. Jordan SC, Toyoda M: Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin. Clin Exp Immunol 1994; 97[Suppl 1]:S31-S38.
17. Hoffman GS, Leavitt RY, Kerr GS, Fauci AS: The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum 1992;35:1322-1329.
18. Jennette JC, Falk RJ, Andrassy K, et al: Nomenclature of systemic vasculitides: The proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192.
19. Falk RJ, Hogan SL, Muller KE, Jennette JC, and The Glomerular Disease Collaborative Network: Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. Ann Intern Med 1992; 116:438-445.
20. Jennette JC, Wilkman AS, Falk RJ: Anti-neutrophil cytoplasmic auto-antibody-associated glomerulonephritis and vasculitis. Am J Pathol 1989;135:921-930.
21. van der Woude FJ, Rasmussen N, Lobatto S, et al.: Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1:425-429.
22. So Y: PROC PHREG: A Procedure for Cox's Proportional Hazards Regression Analysis. SAS Institute Inc., Application Division, SAS Users Group International Conference, 1991.
23. Harrell FE, Lee KL. Verifying assumptions of the Cox proportional hazards model. In: Proceedings of the Eleventh International Conference of the SAS User's Group, Atlanta, GA, 1986:823-828.
24. SAS Institute Inc. SAS/GRAPH Software. Version 6, Volume 1. Cary, NC: SAS Institute Inc., 1990.
25. Nachman PH, Hogan SL, Jennette JC, Falk RJ: Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996;7:33-39.
26. Peters DK, Rees AJ, Lockwood CM, Pusey CD: Treatment and prognosis in antibasement membrane antibody mediated nephritis. Transplant Proc 1982;14:513-515.
27. Levey AS, Lan SP, Corwin HL, et al: Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide. Ann Intern Med 1992;116:114-123.
28. D'Amico G, Ferrario F, Rastaldi MP: Tubulointerstitial Damage in Glomerular Diseases: Its Role in the Progression of Renal Damage. Am J Kidney Dis 1995;26:124-132.
29. Adu D, Howie AJ, Scott DG, Bacon PA, McGonigle RJ, Michael J: Polyarteritis and the kidney. Q J Med 1987; 239:221-237.
30. Serra A, Cameron JS, Turner DR, et al.: Vasculitis affecting the kidney: Presentation, histopathology and long-term outcome. Q J Med 1984;210:181-207.